The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Early lung cancer diagnostic biomarker discovery by machine learning methods
Open accessAbstract
Early diagnosis has been proved to improve survival rate of lung cancer patients. The availability of blood-based screening could increase early lung cancer patient uptake. Our present study attempted to discover Chinese patients' plasma metabolites as diagnostic biomarkers for lung cancer. In this work, we use a pioneering interdisciplinary mechanism, which is firstly applied to lung cancer, to detect early lung cancer diagnostic biomarkers by combining metabolomics and machine learning methods. We collected total 110 lung cancer patients and 43 healthy individuals in our study. Levels of 61 plasma metabolites were from targeted metabolomic study using LC-MS/MS. A specific combination of six metabolic biomarkers note-worthily enabling the discrimination between stage I lung cancer patients and healthy individuals (AUC = 0.989, Sensitivity = 98.1%, Specificity = 100.0%). And the top 5 relative importance metabolic biomarkers developed by FCBF algorithm also could be potential screening biomarkers for early detection of lung cancer. Naïve Bayes is recommended as an exploitable tool for early lung tumor prediction. This research will provide strong support for the feasibility of blood-based screening, and bring a more accurate, quick and integrated application tool for early lung cancer diagnostic. The proposed interdisciplinary method could be adapted to other cancer beyond lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
Non-small-cell lung cancers: a heterogeneous set of diseases
Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F., & Wong, K.-K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3775 · Cited by 1,942
Travis, W. D., Brambilla, E., Burke, A. P., Marx, A., & Nicholson, A. G. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000663 · Cited by 1,905
Orange: data mining toolbox in python
Demšar, J., Curk, T., Erjavec, A., Gorup, Č., Hočevar, T., Milutinovič, M., Možina, M., Polajnar, M., Toplak, M., Starič, A., et al. (2013) · Journal of Machine Learning Research · Cited by 1,655
The Ensembl genome database project
Hubbard, T. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.38 · Cited by 1,637
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
(2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20063 · Cited by 1,528
Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J., Chirieac, L. R., D'Amico, T. A., DeCamp, M. M., Dilling, T. J., Dobelbower, M., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0050 · Cited by 1,303
Integrating genomic features for non-invasive early lung cancer detection
Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., Schroers-Martin, J., Nabet, B. Y., Chen, B., Chaudhuri, A. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2140-0 · Cited by 685
Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges
Huang, S., Yang, J., Fong, S., & Zhao, Q. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.007 · Cited by 672
Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis
Ambale-Venkatesh, B., Yang, X., Wu, C. O., Liu, K., Hundley, W. G., McClelland, R., Gomes, A. S., Folsom, A. R., Shea, S., Guallar, E., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311312 · Cited by 639
Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment
Pinsky, P. F., Gierada, D. S., Black, W., Munden, R., Nath, H., Aberle, D., & Kazerooni, E. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2086 · Cited by 508
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Zhang, D., Li, J., Wang, F., Hu, J., Wang, S., & Sun, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.003 · Cited by 462
Rashidi, H. H., Tran, N. K., Betts, E. V., Howell, L. P., & Green, R. (2019) · Academic Pathology · doi:10.1177/2374289519873088 · Cited by 371
Spermidine/spermine-N1-acetyltransferase: a key metabolic regulator
Pegg, A. E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90217.2008 · Cited by 349
Prediction of lung cancer patient survival via supervised machine learning classification techniques
Lynch, C. M., Abdollahi, B., Fuqua, J. D., de Carlo, A. R., Bartholomai, J. A., Balgemann, R. N., van Berkel, V. H., & Frieboes, H. B. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.09.013 · Cited by 333
Proline Metabolism in Cell Regulation and Cancer Biology: Recent Advances and Hypotheses
Phang, J. M. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7350 · Cited by 296
Urine Metabolomics Analysis for Kidney Cancer Detection and Biomarker Discovery
Kim, K., Aronov, P., Zakharkin, S. O., Anderson, D., Perroud, B., Thompson, I. M., & Weiss, R. H. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800165-mcp200 · Cited by 271
Development of machine learning models for diagnosis of glaucoma
Kim, S. J., Cho, K. J., & Oh, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177726 · Cited by 266
Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma
Zhang, B., He, X., Ouyang, F., Gu, D., Dong, Y., Zhang, L., Mo, X., Huang, W., Tian, J., & Zhang, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.004 · Cited by 246
Early Stage Diagnosis of Oral Cancer Using 1H NMR–Based Metabolomics
Tiziani, S., Lopes, V., & Günther, U. L. (2009) · Neoplasia · doi:10.1593/neo.81396 · Cited by 237
Zhao, W., Yang, J., Sun, Y., Li, C., Wu, W., Jin, L., Yang, Z., Ni, B., Gao, P., Wang, P., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0696 · Cited by 226
Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning
Mucaki, E. J., Zhao, J. Z. L., Lizotte, D. J., & Rogan, P. K. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0034-5 · Cited by 200
Colorectal Cancer Detection Using Targeted Serum Metabolic Profiling
Zhu, J., Djukovic, D., Deng, L., Gu, H., Himmati, F., Chiorean, E. G., & Raftery, D. (2014) · Journal of Proteome Research · doi:10.1021/pr500494u · Cited by 200
Liu, W., Hancock, C. N., Fischer, J. W., Harman, M., & Phang, J. M. (2015) · Scientific Reports · doi:10.1038/srep17206 · Cited by 171
Alleviating naive Bayes attribute independence assumption by attribute weighting
Zaidi, N. A., Cerquides, J., Carman, M., & Webb, G. I. (2013) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.13039/501100000923 · Cited by 167
Jeon, J., Nim, S., Teyra, J., Datti, A., Wrana, J. L., Sidhu, S. S., Moffat, J., & Kim, P. M. (2014) · Genome Medicine · doi:10.1186/preaccept-8096551512514564 · Cited by 166
Xu, W., Xu, M., Wang, L., Zhou, W., Xiang, R., Shi, Y., Zhang, Y., & Piao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0081-6 · Cited by 160
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
Jin, X., Yun, S., Jeong, P., Kim, I., Kim, W., & Park, S. (2014) · OncoTarget · doi:10.18632/oncotarget.1744 · Cited by 140
Urayama, S., Zou, W., Brooks, K., & Tolstikov, V. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4420 · Cited by 137
Kitazono, S., Fujiwara, Y., Tsuta, K., Utsumi, H., Kanda, S., Horinouchi, H., Nokihara, H., Yamamoto, N., Sasada, S., WATANABE, S.-I. J., et al. (2015) · Clinical Lung Cancer · doi:10.1016/j.cllc.2015.03.008 · Cited by 137
Guan, W., Zhou, M., Hampton, C. Y., Benigno, B. B., Walker, L. D., Gray, A., McDonald, J. F., & Fernández, F. M. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-259 · Cited by 129
Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments
Liu, W., Glunde, K., Bhujwalla, Z. M., Raman, V., Sharma, A., & Phang, J. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0080 · Cited by 123
Srivastava, S., Roy, R., Singh, S. K., Kumar, P., Dalela, D., Sankhwar, S., Goel, A., & Sonkar, A. A. (2009) · Cancer Biomarkers · doi:10.3233/cbm-2009-0115 · Cited by 116
Radiomics in stratification of pancreatic cystic lesions: Machine learning in action
Dalal, V., Carmicheal, J., Dhaliwal, A., Jain, M., Kaur, S., & Batra, S. K. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.023 · Cited by 113
Yang, Q., Zhang, P., Wu, R., Lu, K., & Zhou, H. (2018) · Disease Markers · doi:10.1155/2018/2082840 · Cited by 103
A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment
Bamji, S. F., van Berkel, V. H., Miller, D. M., & Frieboes, H. B. (2018) · Metabolomics · doi:10.1007/s11306-018-1376-2 · Cited by 101
Nindrea, R. D., Aryandono, T., Lazuardi, L., & Dwiprahasto, I. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.7.1747 · Cited by 101
Using Information from Historical High-Throughput Screens to Predict Active Compounds
Riniker, S., Wang, Y., Jenkins, J. L., & Landrum, G. A. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500190p · Cited by 96
Self-citationMechanism of taurine-induced apoptosis in human colon cancer cells
Zhang, X., Tu, S., Wang, Y., Xu, B., & Wan, F. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu004 · Cited by 91
Self-citationCirculating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk
Chuang, S.-C., Fanidi, A., Ueland, P. M., Relton, C. L., Midttun, Ø., Vollset, S. E., Gunter, M. J., Seckl, M. J., Travis, R. C., Wareham, N. J., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0770 · Cited by 91
Kynurenine metabolism in health and disease
Kolodziej, L. R., Paleolog, E. M., & Williams, R. O. (2010) · Amino Acids · doi:10.1007/s00726-010-0787-9 · Cited by 90
Ko, J., Bhagwat, N., Black, T. A., Yee, S. S., Na, Y.-J., Fisher, S., Kim, J., Carpenter, E. L., Stanger, B. Z., & Issadore, D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3703 · Cited by 87
Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients
Agouza, I. M. E., Eissa, S. S., Houseini, M. M. E., El-Nashar, D. E., & Hameed, O. M. A. E. (2011) · Angiogenesis · doi:10.1007/s10456-011-9215-3 · Cited by 85
Cancer progression is mediated by proline catabolism in non-small cell lung cancer
Liu, Y., Mao, C., Wang, M., Liu, N., Ouyang, L., Liu, S., Tang, H., Cao, Y., Liu, S., Wang, X., et al. (2020) · Oncogene · doi:10.1038/s41388-019-1151-5 · Cited by 79
Self-citationArtificial Intelligence in Obstetrics and Gynaecology: Is This the Way Forward?
Emin, E. I., Emin, E., Papalois, A. E., Willmott, F., Clarke, S. D., & Sideris, M. C. (2019) · In Vivo · doi:10.21873/invivo.11635 · Cited by 71
Cooper, W. A., O'Toole, S. A., Boyer, M. J., Horvath, L. G., & Mahar, A. M. (2011) · Pathology · doi:10.1097/pat.0b013e328342629d · Cited by 67
Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells
Tu, S., Zhang, X., Wan, H., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8036 · Cited by 67
Shi, P., Ray, S., Zhu, Q., & Kon, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-375 · Cited by 66
Obrzut, B., Kusy, M., Semczuk, A., Obrzut, M., & Kluska, J. (2017) · BMC Cancer · doi:10.1186/s12885-017-3806-3 · Cited by 62
The Evolving Role of Taurolidine in Cancer Therapy
Neary, P., Hallihan, P., Wang, J. H., Pfirrmann, R. W., Bouchier‐Hayes, D. J., & Redmond, H. P. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0867-9 · Cited by 61
Babbar, N., Hacker, A., Huang, Y., & Casero, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601871200 · Cited by 58
Zhang, H., Ren, J.-X., Ma, J., & Ding, L. (2018) · Molecular Diversity · doi:10.1007/s11030-018-9882-8 · Cited by 52
Kyrgiou, M., Pouliakis, A., Panayiotides, J. G., Margari, N., Bountris, P., Valasoulis, G., Paraskevaidi, M., Bilirakis, E., Nasioutziki, M., Loufopoulos, A., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.12.032 · Cited by 47
Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma
Li, L., Chen, J., Chen, X., Tang, J. P., Guo, H., Wang, X., Qian, J., Luo, G., He, F., Lu, X., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.028 · Cited by 46
Suguro, R., Pang, X., Yuan, Z., Chen, S., Zhu, Y. Z., & Xie, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104519 · Cited by 39
Self-citationIncorporation of glucose into glycogen in primary cultures of rat hepatocytes
Parniak, M. A., & Kalant, N. (1985) · Canadian Journal of Biochemistry and Cell Biology · doi:10.1139/o85-049 · Cited by 38
Huang, Y., Zhu, J., Li, W., Zhang, Z., Xiong, P., Wang, H., & Zhang, J. (2017) · Oncology Reports · doi:10.3892/or.2017.6163 · Cited by 32
Ahmed, M. S., Shahjaman, M., Rana, M. M., & Mollah, M. N. H. (2017) · BioMed Research International · doi:10.1155/2017/3020627 · Cited by 28
Metabolic Intermediates in Tumorigenesis and Progression
He, Y., Gao, M., Tang, H., Cao, Y., Liu, S., & Tao, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33496 · Cited by 26
Luo, S., Xu, J., Jiang, Z., Liu, L., Wu, Q., Leung, E. L., & Leung, A. P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105037 · Cited by 26
Self-citationUsefulness of recurrence plots from airflow recordings to aid in paediatric sleep apnoea diagnosis
Barroso-García, V., Gutiérrez‐Tobal, G. C., Gozal, D., Álvarez, D., Vaquerizo-Villar, F., Nùñez, P., del Campo, F., Gozal, D., & Hornero, R. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.105083 · Cited by 25
Functional microRNA screening using a comprehensive lentiviral human microRNA expression library
Poell, J. B., van Haastert, R. J., Cerisoli, F., Bolijn, A. S., Timmer, L. M., Diosdado, B., Meijer, G. A., van Puijenbroek, A. A. F. L., Berezikov, E., Schaapveld, R. Q. J., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-546 · Cited by 19
Wang, H., Chen, J., Feng, Y., Zhou, W., ZHANG, J., Yu, Y. U., Wang, X., & ZHANG, P. (2015) · Oncology Letters · doi:10.3892/ol.2015.3128 · Cited by 17
Pan, H., Zheng, Y., Liu, Z., Yuan, Z., Ren, R., Zhou, H., Xie, Y., & Liu, L. (2019) · Frontiers of Medicine · doi:10.1007/s11684-018-0676-2 · Cited by 8
Self-citation
Cited by
Ponce‐Bobadilla, A. V., Schmitt, V., Maier, C. S., Mensing, S., & Stodtmann, S. (2024) · Clinical and Translational Science · doi:10.1111/cts.70056 · Cited by 826
Evaluation of artificial intelligence techniques in disease diagnosis and prediction
Ghaffar Nia, N., Kaplanoglu, E., & Nasab, A. (2023) · Discover Artificial Intelligence · doi:10.1007/s44163-023-00049-5 · Cited by 426
Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., & Vale, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030332 · Cited by 390
Artificial intelligence assists precision medicine in cancer treatment
Liao, J., Li, X., Gan, Y., Han, S., Rong, P., Wang, W., Li, W., & Zhou, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.998222 · Cited by 256
Metadata
- Authors
- Xie, Y., Meng, W.-Y., Li, R.-Z., Wang, Y.-W., Qian, X., Chan, C., Yu, Z.-F., Fan, X.-X., Pan, H.-D., Xie, C., Wu, Q.-B., Yan, P.-Y., Liu, L., Tang, Y.-J., Yao, X.-J., Wang, M.-F., & Leung, E. L.-H.
- Venue
- Translational Oncology
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 14
- Issue
- 1
- Pages
- 100907
- ISSN
- 1936-5233 (ISSN-L)
- OpenAlex
- W3105613063
- Cited by
- 269
- References
- 64
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.